Saturday, February 25, 2023

Missed Our Webinar on “Breast Cancer Talks”? Watch Here!

Dear Dr. Renukaprasad A R,
Do you know abemaciclib reduces the risk of distant recurrence by approximately 34% in breast cancer patients?
Abemaciclib is the most recent oral cyclin-dependent kinase 4 and 6 inhibitor used for treating hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer (MBC). It has also been shown to reduce the rate of recurrence among breast cancer patients.
Have you missed the webinar?
Don't worry! We have saved the recording just for YOU!

We hope you find the session useful.
Docplexus: One of the world's largest online communities of Doctors
Pune - 411045, India
info@docplexus.co.in�� |� +91 98500 36954
You are receiving this communication because you are registered member of Docplexus.
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

India: AIIMS to Introduce Startup Policy for Medical Students, and More

Docplexus: One of the world's largest online communities of Doctors
Pune - 411045, India
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Friday, February 24, 2023

Join the "Bariatric Endoscopy: Latest Development" Session

Dear Dr. Renukaprasad A R,
Endoscopy has become an effective tool in the armamentarium of bariatric surgeons for evaluation, diagnosis, management of complications, and even for primary bariatric interventions. Therefore, having skills and sound knowledge of advanced endoscopic procedures is essential for bariatric surgeons to manage morbid obesity in patients.
Join the expert gastroenterologist, Dr. Rakesh Kalapala, in our exclusive session on "Bariatric Endoscopy: Current Scenario," TODAY, 6:00 PM IST onwards.
Docplexus: One of the world's largest online communities of Doctors
Pune - 411045, India
info@docplexus.co.in�� |� +91 98500 36954
You are receiving this communication because you are registered member of Docplexus.
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Thursday, February 23, 2023

Case of the Week: Vision Disturbance Post-COVID Vaccine